Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity
11 feb. 2021 et al. Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate Covid-19: a randomized clinical trial ...
REMDESIVIR PARA EL TRATAMIENTO DE INFECCION POR
18 may. 2020 J Biol Chem 2020;295:4773-9. 14 Agostini ML Andres EL
Repurposed antiviral drugs for COVID-19 –interim WHO
15 oct. 2020 Lyon F Ader*§; Institut National de la Santé Et de la Recherche Médicale ... trials in hospitalized COVID-19 of four re-purposed antiviral.
Nunes E.P. etal FIOCRUZ COVID PREPRINT
Revisión del efecto antiviral
Zhang W Zhao Y
revision del efecto antiviral
Chloroquine hydroxychloroquine et COVID-19 : Évaluation
10 nov. 2020 1) Chloroquine hydroxychloroquine et COVID-19 : données de la ... son utilisation comme agent antiviral dans le traitement du COVID-19.
hydroxy chloroquine et covid
Eficacia y Seguridad de Molnupiravir para el tratamiento de COVID-19
Fischer W Eron JJ
COVID-19 Antiviral and Pharmacotherapy Recommendations
17 mar. 2020 COVID-19 Antiviral and Pharmacotherapy Recommendations ... 3) Cortegiana et al. A systematic review on the efficacy and safety of ...
covid antiviral pharmacotherapy recommendations
Antiviral Drug Discovery for the Treatment of COVID-19 Infections
4 may. 2022 Keywords: antiviral; COVID-19; SARS-CoV-2; drug discovery; ... et al. SARS-CoV-2 Omicron neutralization by therapeutic antibodies ...
What Clinicians Need to Know About the New Oral Antiviral
12 ene. 2022 What Clinicians Need to Know About the New. Oral Antiviral Medications for COVID-19 ... Lu et al https://pubmed.ncbi.nlm.nih.gov/34915551/.
slide
INSTITUTO NACIONAL DE SALUD Opciones terapéuticas contra
21 feb. 2022 La enfermedad Covid-19 causada por el virus SARS-CoV-2